Can Rabies Immunoglobulin Be Given With Vaccine?
Yes, human rabies immune globulin (HRIG) must be administered concurrently with the first dose of rabies vaccine on day 0 for previously unvaccinated persons exposed to rabies. This combination provides both immediate passive immunity and initiates active immunity, which is essential for preventing this uniformly fatal disease. 1
Administration Protocol for Previously Unvaccinated Persons
Timing and Concurrent Administration
- HRIG and vaccine are given together on day 0 (the day of first vaccine dose) as part of standard post-exposure prophylaxis (PEP). 1
- If HRIG was not given on day 0, it can still be administered up to and including day 7 of the vaccine series. 1, 2
- After day 7, HRIG should not be given, as vaccine-induced antibody production is presumed to have occurred. 3
Critical Administration Requirements
HRIG and vaccine must NEVER be administered:
However, subsequent vaccine doses (days 3,7, and 14) can be administered in the same anatomic location where HRIG was previously given. 1
Dosing and Site Selection
- HRIG dose: 20 IU/kg body weight for all ages, including children 1, 3
- Wound infiltration: The full HRIG dose should be infiltrated around and into the wound(s) if anatomically feasible 1
- Remaining volume: Any HRIG not used for wound infiltration is injected intramuscularly at a site distant from the vaccine injection 1
- Vaccine site: Deltoid area for adults and older children; anterolateral thigh for infants and young children 1, 3
Rationale for Concurrent Administration
Complementary Mechanisms
- HRIG provides immediate passive immunity with rabies virus-neutralizing antibodies appearing within 24 hours, bridging the gap until active immunity develops 1, 4
- Vaccine induces active immunity but requires approximately one week to produce protective antibody levels 2
- This dual approach is uniformly effective when appropriately administered for preventing rabies after exposure 2
Evidence of Safety and Efficacy
- Field experience from multiple areas worldwide confirms the effectiveness of combined HRIG and vaccine administration 2
- Studies demonstrate that 20 IU/kg HRIG provides maximum circulating antibody with minimal interference of active immunization 2
- No significant interference with vaccine-induced antibody response occurs when HRIG and vaccine are given together, as evidenced by additive antibody effects observed by day 7 5
- Clinical trials show 93-100% of patients achieve protective RVNA levels (≥0.5 IU/mL) by day 14 when HRIG is combined with vaccine 6
Common Pitfalls and How to Avoid Them
Dosing Errors
- Do not exceed 20 IU/kg of HRIG, as higher doses can partially suppress active antibody production 1, 3
- Do not reduce HRIG dose below recommended levels, as this may compromise passive immunity 1
Administration Site Errors
- Never use the gluteal area for vaccine, as this results in diminished immunologic response 1, 3
- Ensure adequate separation between HRIG and vaccine injection sites for the first dose 1
Wound Infiltration Failures
- Real-world data shows only 56% of eligible patients receive proper wound infiltration despite guidelines 7
- Prioritize infiltrating all anatomically accessible wounds with HRIG before giving any remainder intramuscularly 1, 7
Previously Vaccinated Persons: The Exception
HRIG should NOT be administered to previously vaccinated persons who have documented prior complete vaccination with cell-culture vaccine and adequate antibody response. 1, 2
- These individuals receive vaccine only (2 doses on days 0 and 3) 1
- Previous vaccination provides immunologic memory, making passive immunization unnecessary 1
Special Populations
Immunocompromised Patients
- Receive the same HRIG dose (20 IU/kg) with vaccine on day 0 1
- Require a 5-dose vaccine series (days 0,3,7,14,28) instead of the standard 4-dose regimen 1, 3